Invited Faculty
Hiroyoshi Yokoi, MD
Fukuoka Sannou Hospital
Japan
| Date |
Time |
Place |
Session / Title |
Role |
| April 25 |
12:45 PM - 1:45 PM |
CTO Theater, Level 1 |
Treating Complex SFA Lesions and Patients with Directional Atherectomy and IN.PACT DCB: Evidence and Real-World Experience |
Moderator |
| April 25 |
1:10 PM - 1:20 PM |
CTO Theater, Level 1 |
Treating Complex SFA Lesions and Patients with Directional Atherectomy and IN.PACT DCB: Evidence and Real-World Experience
IN.PACT Admiral DCB: Results from the Japan Randomized Control Trial |
Lecturer |
| April 25 |
1:40 PM - 1:45 PM |
CTO Theater, Level 1 |
Treating Complex SFA Lesions and Patients with Directional Atherectomy and IN.PACT DCB: Evidence and Real-World Experience
Closing Remarks |
Speaker |
| April 25 |
2:00 PM - 3:00 PM |
Endovascular Theater, Level 1 |
Live Case Session III. BTK Intervention |
Discussant |
| April 26 |
7:00 AM - 8:10 AM |
Valve Theater, Level 1 |
Peripheral Vascular Intervention |
Panelist |
| April 26 |
7:16 AM - 7:24 AM |
Valve Theater, Level 1 |
Peripheral Vascular Intervention
Biologic and Mechanical Suppression for Restenosis: Drug-Eluting Stent |
Lecturer |
| April 26 |
10:00 AM - 11:15 AM |
Valve Theater, Level 1 |
VIVA Highlights @ TCTAP 2017 |
Panelist |
| April 26 |
10:20 AM - 10:30 AM |
Valve Theater, Level 1 |
VIVA Highlights @ TCTAP 2017
12-Month Results from the MDT-2113 SFA Japan trial - DCB vs. Standard PTA for SFA and Proximal Popliteal Disease |
Lecturer |
| April 26 |
11:15 AM - 12:30 PM |
Valve Theater, Level 1 |
VIVA Highlights @ TCTAP 2017 |
Panelist |
| April 26 |
12:05 PM - 12:15 PM |
Valve Theater, Level 1 |
VIVA Highlights @ TCTAP 2017
Zilver PTX Stent for CLI - Insights from the Japan Post Market Study |
Lecturer |
| April 26 |
4:40 PM - 5:30 PM |
Case Zone III, Level 3 |
3-9. Endovascular Intervention |
Moderator |
